MedPath

Cell-free DNA: a Non-invasive Test for Assessing Embryo Quality

Completed
Conditions
DNA
Culture Media
Registration Number
NCT01397136
Lead Sponsor
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Brief Summary

In the present project we propose to deeply characterize nuclear and/or mitochondrial DNA in embryo culture medium, in order to investigate whether both cell-free nucleic acid types may provide additional, reliable, predictive parameters for embryo viability and implantation potential.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
600
Inclusion Criteria
  • We will enroll in the study only embryos obtained from fresh gametes. It is to note that we currently transfer more than one embryo (with a maximum of 3, according to patient's age) and we will follow such criteria alongside the project. Consequently, we will take into consideration this aspect in correlating DNA parameters with embryo's outcome.
Exclusion Criteria
  • We will exclude cryopreserved embryos, in order to avoid potential biases due to cooling/defrosting procedures.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Isolation and characterization of nuclear and/or mitocondrial DNA into embryo culture mediumMonth 6 of the project
Secondary Outcome Measures
NameTimeMethod
Prediction of high quality embryos according to molecular profiling of cell-free DNA released into culture medium.Month 12 of the project
Publication of scientific reports.Month 12 of the project
Dissemination of results by participating at national and international meetings, workshops and specific courses.Months 3-12 of the project

Trial Locations

Locations (1)

IRCCS AOU San Martino-IST

🇮🇹

Genova, GE, Italy

© Copyright 2025. All Rights Reserved by MedPath